Every article, presentation, spotlight, and news item we've tagged to Aesthetics, Skin, and Spa.
Scientists discovered how NAD+, exosomes, and DNA repair enzymes can reverse skin aging at the cellular level. Young Goose harnesses these longevity pathways to regenerate skin from within.
Discover how cutting-edge cellular technology is transforming skincare from within. Amitay Eshel, Co-Founder of Young Goose, reveals breakthrough approaches using NAD+ and exosome technology to target skin aging at the cellular level. This session explores the intersection of longevity science and beauty, demonstrating how biohacking principles can revolutionize skin health by addressing root causes rather than surface symptoms. Learn practical strategies for optimizing cellular regeneration, enhancing skin vitality, and achieving lasting results through science-backed interventions that work from the inside out.
Your mitochondria contain light-sensitive proteins that trigger cellular repair and energy production when exposed to specific infrared wavelengths. Modern indoor living has created a light deficiency that affects everything from energy to immunity.
Parallel Health's Metabolic Microbiome Profiling measures what skin microbes actively produce—vitamins, antioxidants, fatty acids, and lipids—rather than merely identifying which organisms are present. This functional approach to skin microbiome analysis enables precision interventions tied to barrier function, immune support, and resilience, positioning the skin microbiome as a measurable diagnostic rather than a marketing concept.
L'Oréal and NUS Medicine are investigating whether skin aging correlates with systemic aging across multiple organ systems in the same participants. This within-person comparison approach could establish skin as a practical biomarker for biological aging, offering an accessible alternative to invasive measures like blood draws and imaging.
FDA clearance of SkinStylus microneedling for periorbital wrinkles across all skin types marks progress toward inclusive regenerative skin treatment. The device activates the skin's natural repair mechanisms rather than masking aging signs, reflecting a broader shift in aesthetic medicine toward structural resilience and maintenance-based approaches.
A non-ablative fractional laser treatment produced measurable shifts in skin epigenetic markers associated with aging, with 83.9% of age-related CpG sites showing DNA methylation changes consistent with biological reversal. Visible improvements in pigmentation and texture paralleled molecular changes over a six-month period, suggesting the intervention operates at both the genetic regulation and tissue-level domains.
DermCeutical EDL, a biotech-engineered ingredient, stimulates fibroblasts to increase elastin production and reduce cellular stress, delivering measurable improvements in skin firmness and fine lines comparable to professional treatments. The development represents a shift toward topical interventions that support cellular function and dermal resilience as part of broader aging resilience.
Parallel Health has developed Metabolic Microbiome Profiling, a technology that maps the functional output of skin microbes rather than merely identifying species presence. This approach links microbial metabolite production—including vitamins, antioxidants, and short-chain fatty acids—to skin aging phenotypes, enabling personalized dermatological intervention based on actual biochemical activity rather than microbial composition alone.
The personal care and longevity industry is shifting from treating visible signs of aging to supporting cellular health upstream, positioning products as maintenance tools for biological function rather than cosmetic fixes. This repositioning extends the customer lifecycle while aligning consumer expectations with the biological mechanisms of aging.
Lancôme and Timeline have partnered to develop a skincare line using urolithin A (Mitopure), a molecule that enhances mitochondrial function in skin cells to address aging at the cellular level rather than merely treating visible signs. This represents a shift in luxury skincare from cosmetic coverage to supporting long-term cellular vitality and resilience.
Acorn Biolabs has initiated a randomized, controlled trial of YOU, an autologous secretome derived from hair follicle stem cells, to treat androgenic alopecia. The study will measure changes in hair density, thickness, and patient outcomes against placebo, establishing whether personalized regenerative approaches offer clinically meaningful advantages over existing pharmacologic treatments.
Veradermics' topical VDPHL01 demonstrated measurable hair regrowth in women with androgenetic alopecia, producing mean increases of 22–23 hairs/cm² at six months and improvement in hair coverage in nearly 90% of participants, with no serious safety signals. These Phase 2 findings support advancement toward confirmatory trials and represent a potential treatment option for female pattern hair loss, where therapeutic options remain limited.
A single 30-minute sauna session at 73°C triggers a transient increase in circulating white blood cells, with neutrophils and lymphocytes rising immediately post-session and returning to baseline within 30 minutes. This mobilization effect suggests a mechanism through which regular sauna use may confer documented cardiovascular and longevity benefits.
A 30-minute sauna session at 73°C triggers acute mobilization of circulating white blood cells across all major subtypes—neutrophils, lymphocytes, and monocytes—without selective recruitment of specific immune populations. This transient spike in immune surveillance capacity may represent a physiological mechanism underlying the epidemiological associations between regular sauna use and reduced cardiovascular disease, stroke, dementia, and all-cause mortality risk.
Fibulin-5, an extracellular matrix protein that declines with age, regulates fast-cycling skin cell populations through the YAP signaling pathway. Mice lacking fibulin-5 exhibit accelerated skin aging phenotypes, including loss of regenerative cell populations and compromised dermal-epidermal integrity, suggesting this protein may be central to maintaining skin renewal capacity across the lifespan.
Allergan Aesthetics is repositioning injectable fillers around 'undetectable' results rather than dramatic transformation, reflecting a measurable shift in consumer preference toward subtle, personalized intervention that respects rather than erases the aging process. This represents a maturation of the aesthetic market toward maintenance-based, individualized support aligned with longevity medicine principles.
Fibulin-5, an extracellular matrix protein that declines with age, maintains populations of fast-cycling skin cells through YAP signaling. Mice lacking fibulin-5 exhibit accelerated skin aging phenotypes, including loss of fast-cycling cells and compromised epidermal-dermal junction integrity, mirroring natural aging processes.
SEMCAP's expansion into beauty and wellness investment signals a structural shift in longevity markets: evidence-backed skincare, haircare, and personalized health products are becoming primary entry points for consumer engagement with aging well, driven by daily rituals and observable body signals rather than clinical diagnostics alone.
Veradermics raised $256 million in its IPO for VDPHL01, an extended-release oral minoxidil formulation designed to maintain steady hair follicle exposure while reducing cardiac side effects associated with immediate-release formulations. Phase 3 trials are underway to validate whether sustained drug delivery improves hair regrowth outcomes compared to existing topical and oral alternatives.
Allergan Aesthetics positions hyaluronic acid injectables toward imperceptible aesthetic outcomes through personalized treatment protocols and practitioner training. This reflects a market shift away from obvious augmentation toward integrated facial harmonization strategies.
Enterprises face structural exposure to longevity risk across workforce, customer base, and balance sheet—yet most organizations treat demographic change as peripheral rather than integrating it into core risk governance. This misalignment creates operational, financial, and strategic vulnerability as populations age across developed markets.
Second harmonic generation imaging combined with multiparametric analysis identifies distinctive collagen structural patterns in breast cancer tissue, enabling detection at the microscopic level before conventional diagnostic methods. These collagen signatures represent a potential early detection pathway that could shift cancer identification upstream in disease progression.
Sugar disrupts skin cells at the functional level, pushing them into senescence and chronic inflammation rather than simply damaging collagen structure. This cellular dysfunction mirrors aging patterns throughout the body, positioning dietary sugar management as foundational to longevity rather than cosmetic skin care.
Wound healing in young skin relies on a coordinated senescence response in fibroblasts that produces tissue-remodeling proteins and supports closure. In aged individuals, this response is both diminished and functionally altered toward inflammation, directly impairing repair capacity and contributing to delayed healing.
Replacement-based interventions—which remove or export molecular, organellar, and cellular damage—offer a mechanistic approach to systemic rejuvenation that could extend healthy lifespan beyond conventional therapeutics. This framework integrates bioengineering strategies with regenerative approaches to address multiple forms of age-related damage simultaneously across tissues and regulatory networks.
A theoretical framework explains why interventions that dramatically extend lifespan in simple organisms produce modest gains in mammals: biological complexity creates redundancy, tissue-specific effects, and compensatory feedback that limit the impact of single-pathway manipulation. This fundamental constraint shapes realistic expectations for longevity interventions across species.
